Menopause is associated with significant symptomatic burden, with approximately two-thirds
of postmenopausal women suffering from vasomotor symptoms, hot flushes, and night …

Purpose: Despite the effectiveness of androgen deprivation therapy in advanced prostate
cancer, serious neuropsychiatric consequences in androgen deprivation therapy (ADT) …

Enzalutamide, an antiandrogen, is approved for therapy of castration resistant prostate
cancer. Clinical applications have shown that approximately 30% of patients acquire …

Importance Previous studies have shown a consistent association between hormone
therapy (HT), such as androgen deprivation therapy, to treat prostate cancer and depression …

Although radiotherapy to the prostate for cancer is effective, recurrence occurs in 10–15%
within 5 years. Traditional salvage treatments for men with radiorecurrent prostate cancer …

Background Previous studies have found an association between androgen deprivation
therapy (ADT) and an increased risk of dementia and depression in elderly men. This …

Prostate cancer (PCa) is the most common malignant tumor in males. The benefits in terms
of overall reduction in specific mortality due to the widespread use of Prostate Specific …

With an increase in the use of androgen deprivation therapy (ADT) in men diagnosed with
prostate cancer, there are several adverse effects that accompany its utilization. Among …

Background Fatigue is a common symptom in cancer patients receiving radiotherapy.
However, previous studies report inconsistent patterns of fatigue change. Aim The aim of this …

Introduction: Androgen deprivation therapy (ADT) is the key of medical treatment for
advanced prostate cancer (PCa), especially in elderly patients. However, the adherence of …